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Abstract: 
Background In international studies, greater investment in primary healthcare is associated with 
improved population health outcomes. 
Aim To determine whether investment in general practice is associated with secondary care 
utilisation, patient satisfaction and clinical outcomes.  
   
Design and setting Retrospective cross-sectional study of general practices in England, 2014/15.  
Methods Practice level data were stratified into three groups according to GP contract type: national 
General Medical Services (GMS) contracts, with or without the capitation supplement (termed, ‘Mean 
Practice Income Guarantee’), or local Personal Medical Services (PMS) contracts. Regression models 
were used to explore associations between practice funding (capitation payments and capitation 
supplements) and secondary care usage, patient satisfaction (General Practice Patient Survey scores) 
and clinical outcomes (QOF scores). We conducted financial modelling to predict secondary care cost 
savings associated with notional changes in primary care funding. 
Results Mean capitation payments per patient: £69.82 in GMS practices in receipt of capitation 
supplements (n=2784); £78.79 in GMS practices without capitation supplements (n=1672); £84.43 in 
PMS practices (n=3022). Mean capitation supplement: £5.72 per patient. Financial modelling 
demonstrated little or no relationship between capitation payments and secondary care costs. In 
contrast, notional investment in capitation supplements was associated with modelled savings in 
secondary care costs. The relationship between funding and patient satisfaction was inconsistent; QOF 
performance was not associated with funding in any practice type.   
 
Conclusions Capitation payments appear to be broadly aligned to patient need in terms of 
secondary care usage. Supplements to the current capitation formula are associated with reduced 
secondary care costs.  
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How this fit in 
In international studies, greater investment in primary healthcare is associated with improved 
population health outcomes and reduced secondary care usage. This is the first national study to 
explore the relationship between core funding allocated to GP practices and objective measures of 
practice outcomes including secondary care utilisation, patient satisfaction and clinical target 
achievement. We found evidence that increased funding to practices in the form of capitation 
supplements was associated with lower levels of secondary care utilisation. Financial modelling has 
been used to illustrate the potential savings in secondary care costs that might be associated with 
additional investment in capitation funding. Findings related to core funding and patient satisfaction 
were mixed; there was no relationship with clinical target achievement.   
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Introduction 
Primary care is often described as the cornerstone of a strong healthcare system. Starfield(1) 
demonstrated across a wide range of international settings that greater investment in primary 
healthcare is associated with improved population health outcomes, reduced secondary care usage 
and reduced overall health costs.(1-4) In spite of this evidence, funding for primary care in England 
has reduced by 6% in real terms, 2005/6 to 2013/14;(5) over the same period overall workload has 
increased by 16%.(6) In contrast, real term secondary care funding has increased by 2% per annum.(7)  
 
International studies of funding in primary care and outcomes have been hampered by lack of 
nationally comparable practice level funding data. In England, general practice funding consists of 
several components (Figure 1), the largest of which are capitation based payments, weighted 
according to factors affecting general practitioner (GP) workload such as the proportion of elderly 
patients or reported prevalence of long term limiting illness.(8, 9). In early 2015, the UK Department 
of Health released the first national summary of general practice funding data, with the promise of 
further details in future years, including summaries of GP earnings.(10) To date, no country outside 
the UK has released similar funding data. We aimed to use these data to explore the association 
between funding and outcomes. Firstly, we wanted to investigate whether the association seen in 
international studies between investment in primary care and lower secondary care costs applied at 
a national level in England.(1) Our secondary aim was to determine the association between primary 
care investment, patient satisfaction and achievement of Quality and Outcomes Framework (QOF) 
targets.(11, 12) Finally, we aimed to use financial modelling in order to  quantify the relationship 
between notional increases in primary care funding and modelled changes in secondary care 
costs.(13) 
 
Methods  
Study design 
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A retrospective cross-sectional study was conducted using practice-level data for the 2014/15 
financial year. In order to adjust for confounding, we obtained practice and demographic 
characteristics.   
 
Practice data 
Descriptive data for all general practices in England were obtained from the General and Personal 
Medical Services database.(14)  Variables which we considered to be associated with practice 
achievement and funding were obtained (Table 1). We included Index of Multiple Deprivation (IMD-
2015) deprivation data, calculated using patient data attributed to Lower Layer Super Output Areas 
(LLSOAs); similarly, we included ethnicity data derived from the 2011 national census and allocated to 
LLSOAs. (15, 16) 
 
Secondary care outcomes 
We obtained data for the year 2014/15 for emergency hospital admissions, hospital admissions for 
Ambulatory Care Sensitive Conditions (ACSCs), Accident and Emergency (A&E) attendances and Out-
Patient attendances from Hospital Episode Statistics, a national database of NHS secondary care 
activity.(17) 
 
General Practice Patient Survey (GPPS) 
The GPPS is an annual survey of patient satisfaction sent to a nationally representative sample of 
patients registered at all general practices in England, with findings reported at practice level. GPPS 
unweighted data were obtained for the 2014 calendar year; weighted data were not used because 
our analysis adjusted for demographic variables.(18) 
 
During 2014, 2.6 million questionnaires were distributed, with an overall response rate of 32.5% 
(858,381 completed responses). This study focussed on responses to the question asking about 
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‘overall satisfaction’ with the general practice (Question 28). Responses were scored according to 
the percentage of patients reporting the most positive of available responses (a ‘very good’ 
experience).  
 
QOF data 
We obtained data from the national QOF dataset covering the financial year, 2014/15. For our analysis, 
we used the total QOF score for each practice. This score is based on achievement of a series of both 
process and outcome targets relating to long term condition management and public health 
targets.(19) 
 
General practice funding data 
We calculated the 2014/15 capitation payment for each practice as ££ per registered patient. We 
defined three different types of practice in England according to the method of allocating capitation 
payments: practices with a national contract (termed ‘General Medical Services’, or ‘GMS’, practices) 
which receive capitation payments weighted according to a needs-based formula (20); GMS practices 
with a national contract which in addition to their weighted capitation payment receive a capitation 
supplement based on higher historical budget allocations (termed ‘Mean Practice Income Guarantee’ 
or ‘MPIG’ payments) (21); practices with a locally negotiated contract (termed ‘Personal Medical 
Services’ or ‘PMS’ practices). A fourth type of practice contract, termed ‘Alternative Personal Medical 
Services’ or ‘APMS’, was excluded from our analysis because we considered that these short term 
contracts may have distorted the relationship between funding and outcomes. We analysed capitation 
payments and capitation supplements separately, in order to determine the relative effects of each 
type of capitation funding.   
 
Participants 
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We linked practice (n=7767) with GPPS data (n=7607 practices) and excluded atypical practices with 
<750 registered patients (n=19), or those with <500 patients (n=22 practices) or > 5000 (n=129 
practices) per full-time equivalent GP following a previously used method.(22) 
 
Statistical analysis 
Univariable analysis was used to identify differences between the three types of general practices 
included in our study. Linear regression models were used to explore the association between practice 
funding, adjusted for confounders, and the following outcome variables: secondary care usage, 
patient satisfaction and QOF achievement (Table 2). Non-normality of outcomes was addressed by re-
checking regression models following logit transformation to normalise the distribution. For the QOF 
analysis, where scores clearly depart from a normal distribution, we repeated the analysis using a logit 
transformed score following the method used previously.(23) This made no appreciable difference to 
the results therefore the un-transformed coefficients are presented here. Model assumptions were 
tested graphically using Q-Q and P-P plots to test for normality of the residuals.   
 
Mean funding per patient was entered into the regression models as a predictor variable. Other 
predictor variables included in the models are shown in Table 2. Funding outliers were removed by 
excluding the highest and lowest funded 2% of practices; further sensitivity analysis was conducted 
by excluding 1% outliers. Multicollinearity was tested using the Variance Inflation Factor (VIF) and 
variables with a value for VIF>10 were excluded. We accounted for local area effects by adjusting for 
clustering at Clinical Commissioning Group (CCG) level. STATA software version 14 (StataCorp, College 
Station, Texas) was used for all statistical analysis.  
 
For the financial modelling, we estimated the effects of a notional 10% increase in capitation funding, 
or a 100% increase in capitation supplement funding, on the secondary care outcome measures. The 
higher percentage increase in capitation supplement was chosen for our model since their value per 
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patient is much smaller than for capitation funding. We obtained secondary care costs using the 
Department of Health reference unit costs for the 2014-2015 financial year.(24) Regression 
coefficients were used to estimate the change in secondary care utilisation rates assuming a notional 
percentage increases in capitation or capitation supplement funding; these changes were converted 
into estimates of primary care costs and projected secondary care savings. A worked example is given 
at the end of Table 3.  Data on ACSC hospital admissions were excluded from the modelling 
assumptions to avoid double counting because ACSC admission costs may have contributed to 
emergency hospital admission costs. 
 
Results 
Following exclusions, the final sample consisted of 7478 practices (96.1% of all practices in England).  
Of these, 4456 (59.6%) practices held GMS contracts (2784 (37.2%) practices received capitation 
supplements; 1672 (22.4%) did not receive capitation supplements); 3022 (40.4%) of practices held 
PMS contracts; Table 1 describes the main characteristics of general practices included in the study, 
their registered populations, and demographic features. 
 
The mean funding per patient in GMS practices in receipt of the capitation supplement was £69.82 
with an additional £5.72 for the capitation supplement (total, £75.54); £78.79 in GMS practices with 
no capitation supplement; £84.43 in PMS practices. The models linking funding and outcomes for 
different practice funding types are illustrated in Table 2. 
 
Secondary care utilisation was not associated or only weakly associated with capitation funding in the 
three types of practices included in our study (Table 2). In contrast, capitation supplements were 
significantly associated with secondary care utilisation: higher levels of capitation supplement were 
associated with reduced A&E attendances (P=0.04), reduced emergency admissions (P<0.001) and 
reduced ACSC admissions (P=0.01).  
9 
 
 
Patient satisfaction was not consistently associated with funding; QOF performance was not 
associated with funding in any of the models (Table 2).  
 
The financial models are summarised in Table 3.  The models only apply to secondary care usage and 
exclude all non-significant values on regression modelling (see Table 2). The only model with 
substantial savings was based on a notional 100% increase in capitation supplements. This resulted in 
an additional cost of £5720 in capitation supplements per 1000 registered patients which was offset 
by modelled secondary care savings of £6280, representing a saving of 110% of the notional 
investment in capitation supplements. Much smaller notional savings in out-patient attendance were 
observed in the only other model which fulfilled the modelling criteria (see Table 2).  
 
Practices in receipt of capitation supplements differed from practices not receiving supplements. They 
had lower weighted capitation payments (Table 2) which was the result of lower Carr-Hill 
weightings.(20) In particular, these practices had fewer registered patients aged ≥75 years (7.69%, 
compared to 8.41% in GMS practices without MPIG; t=-7.35; P<0.001), fewer with limiting long term 
illness (index values of 95.8 and 110.4, respectively; t=-22.74; P<0.001) and lower levels of deprivation 
(IMD-2015 values of 22.52 and 30.38, respectively; t=-14.87; P<0.001).  
 
Sensitivity analyses 
We repeated the analysis excluding the 1% outliers and obtained almost identical results in terms of 
the strength and significance of the relationship between funding and each included outcome. We 
also repeated our analysis on the 2013/14 dataset, the first year for which funding data was released. 
Although much data were missing in this sample, we found similar strength and significance of 
relationship between funding and outcomes.(25)  
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Discussion: 
Summary 
Of the three models of general practice included in our study, only practices in receipt of capitation 
supplements (MPIG payments) demonstrated a clear association between higher levels of funding and 
reduced secondary care utilisation; in these practices, it was additional capitation supplements rather 
than additional capitation payments which were associated with reduced secondary care use. When 
applied to practices in receipt of capitation supplements, modelled secondary care savings exceeded 
the notional cost of additional investment in capitation payments. Practices in receipt of capitation 
supplements differed from other practices. They had lower weighted capitation payments, indicative 
of lower ‘needs-based’ funding, a function of a younger healthier population situated in more 
prosperous areas and the likely explanation for lower baseline secondary care utilisation values. These 
practices had been protected from financial loss through receipt of capitation supplements following 
the introduction of the 2004 GP Contract.(26)  
  
In PMS practices, we found no evidence that additional investment was associated with any of the 
outcomes included in our study. PMS practices have additional locally based clinical targets as part of 
their contract which we were unable to study, reduction of secondary care usage was not one of the 
stated goals of PMS practices (27) and additional funding may have been redirected to local target 
achievement; alternatively, better funded PMS practices may have reached a funding level where 
additional funding failed to release further secondary care savings. Differences in baseline secondary 
care utilisation did not appear to provide an explanation because unadjusted utilisation rates were 
higher in PMS practices whereas the largest modelled reductions in utilisation were found in practices 
with lower baseline utilisation. The lack of association between funding and reported patient 
satisfaction is unexpected; the alignment between PMS practice funding and the need to address local 
priorities could have been expected to translate into higher satisfaction.  
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Financial modelling has demonstrated a divergence, in terms of secondary care usage, between 
modelled increases in capitation payments (in GMS and PMS practices) and capitation supplements 
(in GMS practices). We hypothesise that capitation funding is broadly allocated according to patient 
need.(20) Increased capitation funding would therefore be directed toward the additional demands 
of patients with greater need for primary care services, thus negating any possible reduction in 
secondary care utilisation. In contrast, the MPIG acts as a supplement to the capitation payment based 
on historical funding rather than an assessment of healthcare needs and is available as additional 
primary care investment.  For practices in receipt of capitation supplements, modelled savings indicate 
that these supplements are cost effective in terms of secondary care savings. Modelled savings are 
likely to have been underestimated since ACSC admissions had to be excluded from the model and 
may have made a further contribution to savings. We hypothesise that capitation supplements are 
invested in primary care activity and staff, increasing the capacity of primary care and correspondingly 
reducing demand on secondary care.(28) 
 
Associations were either absent or weak between practice funding and outpatient attendance. 
Although additional funding might allow the practice more time for elective work, other studies have 
reported that investment in additional specialist training did not reduce outpatient referrals.(29)  
 
Similarly, no association was found between additional capitation based funding and QOF 
performance, probably because QOF as an incentive scheme is separately funded (Figure 1). Although 
difficult to cost, and not part of our financial modelling, we found some evidence linking additional 
funding in GMS practices with higher patient reported satisfaction.  
  
 
Strengths and limitations  
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Our study is the first to explore the relationship between practice level funding and secondary care 
usage. We have been able to estimate values for modelled savings and the implication that 
supplements to capitation payments are invested in supporting the management of patients in 
primary care who might otherwise have required emergency care or hospitalisation. A variety of 
sensitivity analyses included in our methodology have confirmed the robustness of our regression 
modelling.  
 
As with all observational studies, significant associations, even if large, may not be causal. We included 
a wide range of potential confounders in our models although residual confounding cannot be 
excluded. There may be other reasons why practices in receipt of MPIG payments demonstrated 
higher potential secondary care savings in our models. Prior to 2004, these practices had higher 
income levels than GMS practices not in receipt of this supplement, and at that time practices with 
higher income were more likely to have been innovative practices investing more in staff, extra 
services and equipment, particularly in more deprived areas, thereby producing better outcomes.(30, 
31) Findings in these practices, although they represent a majority of GMS practices, may not 
generalise to other practices.  Finally, our findings relate to capitation based payments and 
supplements which only account for 55% of practice funding; further study is needed on the 
relationship between other funding sources and measurable primary care outcomes.  
 
Comparison with existing literature 
Recent work in Scotland has shown a mismatch between primary care funding and clinical need, 
providing further evidence of the inverse care law.(32) Similarly, GP payments in England have been 
found to correlate negatively with some healthcare need predictors such as deprivation, non-white 
ethnicity and multi-morbidity.(33) However, neither study included secondary care outcomes or 
financial modelling in their analyses. An observational study examining the relationship between 
funding, contract status and QOF score in general practices care found that GMS practices were the 
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most efficient, achieving higher QOF scores with less funding.(34) However, the authors did not report 
on the role of MPIG payments in their findings and the study sample was limited to 164 practices. In 
contrast, our national dataset did not show a relationship between GP funding and QOF. Given the 
long term trend for transferring care out of hospitals into the community and the lack of real increases 
in general practice capitation funding, more studies are needed on the consequences of these shifts 
in the locus of care.  
 
Implications for research and/or practice 
There is increasing acceptance from UK policy makers that primary care requires a larger share of 
healthcare funding.(35, 36) However, more detailed models are required to guide investment 
decisions based on economic efficiency. This study provides new evidence that primary care 
investment could translate into reductions in secondary care costs although longitudinal evaluation 
would offer stronger evidence of a causal relationships. Our findings suggest that capitation payments 
are broadly aligned to patient need, at least in terms of secondary care usage. However, supplements 
to the current capitation formula may produce a reduction in secondary care costs. If our findings are 
borne out by further studies, proposed reductions in capitation supplements may be 
counterproductive.  
 
 
 
 
Word count: 2710 
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Table 1. 
Characteristics of general practices and their populations in England, 2014–2015 (n = 7478) 
  
Mean 
value 
 
SD 
5th 
centile 
95th 
centile 
Practice list size 7301 4376 2080 15017 
List size per FTE GP† 1794 684.8 963 3142 
Total FTE GP† 4.22 2.74 1.00 9.06 
Proportion GP partners as a total of all GPs, %† 71.3 27.3 23.8 100.0 
Proportion of GPs aged 60 years or above, %† 14.8 26.69 0.00 100.0 
Total practice staff FTE† 11.5 7.4 3.3 24.5 
Proportion Nurse FTE, %† 16.4 6.4 7.3 26.7 
Proportion of postgraduate GP training practices, 
%† 25.2 43.4 0.0 100.0 
Proportion of dispensing practices, %† 14.5 35.2 0.0 100.0 
Carr-Hill nursing and residential home patient 
index† 1.00 0.01 1.00 1.00 
Carr-Hill practice average long-standing illness 
index† 102.4 21.8 71.2 139.9 
IMD-2015 score† 23.7 11.8 8.2 46.2 
Black/Black British, %† 4.1 6.6 0.10 19.7 
Asian/Asian British, %† 9.1 13.4 0.5 41.2 
Age 0–4 years, %† 6.1 1.7 3.7 9.2 
Age 65- 74 years, %† 9.2 3.5 3.4 14.8 
Age ≥75 years, %† 7.6 3.3 2.6 12.8 
Practice A&E attendance rate, per 1000 registered 
patients, per year 
324.9 114.8 187.1 527.0 
Practice Emergency hospital admissions rate, per 
1000 registered patients, per year 
88.8 25.8 54.3 129.7 
Practice ACSC hospital admission rate, per 1000 
registered patients, per year 
15.6   5.8   8.1 25.4 
Practice outpatient attendance rate, per 1000 
registered patients, per year 
64.9 16.4 43.9 91.9 
Total QOF points 530.4 38.4 457.7 559.0 
Overall experience of GP surgery “very good” 
(GPPS), % 
49.3 14.2 26.4 73.4 
 
† Predictor variables included in regression models. Also included in models (not shown in table 
above): region (London, South of England, Midlands, North of England) 
A&E = accident and emergency. ACSC = ambulatory care sensitive conditions.  FTE = full-time 
equivalent. GPPS = General Practice Patient Survey. IMD = Index of Multiple Deprivation. QOF = Quality 
and Outcomes Framework. SD = standard deviation 
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Table 2. The relation between practice funding types and secondary care utilisation, patient 
satisfaction and QOF scores: multivariable regression models. 
 
 
 
 
Practice funding types and outcomes 
Mean 
value  
Mean cost 
per patient 
(5th, 95th centile 
Multivariable regression models:  
funding (££ per patient) as the predictor 
variable of interest 
r2 B 95% CI P 
  
GMS practices, no MPIG (n=1607) 
values for capitation funding   
£78.79 
(66.17, 106.42)  
A&E attendance per 1000 regd patients 354.2  0.36 -0.35 -1.08, 0.38 0.30 
Emerg admissions per 1000 regd patients 97.9  0.48 -0.04 -0.13, 0.05 0.34 
ACSC admissions per 1000 regd patients 17.5  0.46 -0.02 -0.04, 0.00 0.19 
OP attendances per 1000 regd patients 67.7  0.14 0.09 0.01, 0.17 0.03* 
QOF total 527.8  0.09 -0.02 -0.17, 0.14 0.85 
Patient satisfaction (very good, %) 48.8  0.31 0.09 0.04, 0.14 <0.01** 
 
GMS practices, with MPIG (n=2726) 
values for capitation funding   
£69.82 
(60.72, 79.36)  
A&E attendance per 1000 regd patients 298.7  0.42 -0.59 -2.00, 0.82 0.41 
Emerg admissions per 1000 regd patients 83.0  0.45 -0.02 -0.28, 0.24 0.87 
ACSC admissions per 1000 regd patients 14.2  0.44 0.63 -0.04, 0.05 0.79 
OP attendances per 1000 regd patients 63.7  0.06 0.19 -0.12, 0.50 0.22 
QOF total 531.6  0.09 0.33  -0.18, 0.84 0.20 
Patient satisfaction (very good, %) 50.6  0.28 0.00 0.00, 0.00 <0.001*** 
       
GMS practices, with MPIG (n=2726) 
values for capitation supplement   
£5.72 
(0.67, 15.02)     
A&E attendance per 1000 regd patients 298.7  0.43 -0.99 -1.94, -0.05 0.04* 
Emerg admissions per 1000 regd patients 83.0  0.48 -0.33 -0.49, -0.17 <0.001*** 
ACSC admissions per 1000 regd patients 14.2  0.46 -0.05 -0.09, -0.01 0.01** 
OP attendances per 1000 regd patients 63.7  0.08 -0.23 -0.48, 0.03 0.08 
QOF total 531.6  0.08 -0.17 -0.56, 0.22 0.4 
Patient satisfaction (very good, %) 50.6  0.27 0.08 -0.07, 0.08 0.83 
 
PMS practices (n=2834) 
values for capitation funding   
£84.43 
(66.68, 107.09)  
A&E attendance per 1000 regd patients 331.9   0.35 0.81 -0.07, 1.70 0.07 
Emerg admissions per 1000 regd patients 89.0  0.52 -0.51 -0.17, 0.06 0.38 
ACSC admissions per 1000 regd patients 15.8  0.52 0.07 -0.20, 0.07 0.32 
OP attendances per 1000 regd patients 64.1  0.15 -0.09 -0.23, 0.06 0.23 
QOF total 531.3  0.10 0.04 -0.09, 0.17 0.5 
Patient satisfaction (very good, %) 48.4  0.44 0.04 -0.09, 0.17 0.56 
16 
 
*P≤0.05;  **P≤0.01;  ***P≤0.001.  
All P values relate to the significance of the regression coefficients, B.  
 
r2 values show the proportion of variation in the outcome that can be explained by the model 
predictors  
 
All attendance and admission rates are mean values, per year.  
 
Emerg admissions = Emergency hospital admissions. ACSC admissions = Ambulatory Care Sensitive 
Condition hospital admissions. OP attendances = Out-Patient attendances. QOF = Quality and 
Outcomes Framework. Patient satisfaction (very good, %) = Overall experience of GP surgery “very 
good”, %, as reported on the General Practice Patient Survey   
 
 
 
 
  
17 
 
Table 3. Financial modelling showing the relationship between modelled changes in practice funding and secondary care costs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NB Modelling was only conducted if regression model coefficients were significant, P<0.05 (see Table 2) 
*financial modelling based on 10% increase in capitation payments 
**financial modelling based on 100% increase in capitation supplement
Practice funding type  Outcome significantly 
associated with capitation 
funding 
Cost of notional increase 
in capitation funding, per 
1000 regd patients 
Modelled savings in 
secondary care costs 
associated with 
notional increase in 
capitation funding 
Modelled secondary care 
savings: savings as a % of 
notional investment in 
primary care † 
 
GMS practices,  
no MPIG 
Out-patient attendances 
per 1000 registered 
patients/year 
£7879* £94* 1.2% 
 
GMS practices,  
with MPIG; 
values for capitation 
funding only 
n/a £6982* n/a n/a 
   
 
 
GMS practices,  
with MPIG;  
values for capitation 
supplement (MPIG) only 
A&E attendance per 1000 
regd patients 
£5720**  £747** 
 
110.0% 
Emerg admissions per 1000 
registered patients/year 
 £5531** 
 
Total: £6278** 
 
 
PMS practices  
 
n/a £8,443* n/a n/a 
18 
 
 
 
 
  † Worked example:   
 
For the practice sample, ‘GMS practices, no MPIG’: 
 
The cost of a notional 10% change in secondary care utilisation is calculated as follows:  
 
10% x £78.79 (mean capitation payment per registered patient) x 0.09 (B coefficient from regression 
model) x £132.00 (Out-Patient attendance per patient, reference cost)  
 
= £93.60 (or £94, to nearest whole number) 
 
The modelled saving is calculated as follows:  
 
£93.60 (cost of modelled saving in secondary care utilisation) x100 ÷ £7879 (Cost of notional 10% 
increase in general practice capitation funding) 
 
= 1.2%   
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Figure 1. 
NHS Payments to General Practices in England for 2014/15 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Capitation payment 
(including capitation 
supplement)
55%
QOF
9%
Enhanced services
10%
Prescribing 
payments
10%
Other payments
16%
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